From April 1, 2023 to June 30, 2023, the company has repurchased 7,283,466 shares, representing 12.03% for $80.48 million. With this, the company has completed the repurchase of 25,222,581 shares, representing 37.22% for $263.74 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.44 USD | -6.12% | -8.46% | -24.91% |
Apr. 12 | Sector Update: Health Care Stocks Lower Friday Afternoon | MT |
Apr. 12 | Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.91% | 437M | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.